Alterations in Peripheral B Cell Subsets Correlate with the Disease Severity of Human Glaucoma
Ling Yu,Yang Chen,Xiang Xu,Qiwei Dong,Wenbo Xiu,Qinyuan Chen,Jinxia Wang,Chong He,Jian Ye,Fang Lu
DOI: https://doi.org/10.2147/jir.s329084
IF: 4.5
2021-09-21
Journal of Inflammation Research
Abstract:Ling Yu, 1, &ast Yang Chen, 2, &ast Xiang Xu, 2 Qiwei Dong, 2, 3 Wenbo Xiu, 2 Qinyuan Chen, 2 Jinxia Wang, 2 Chong He, 2, 3 Jian Ye, 1 Fang Lu 2, 3 1 Department of Ophthalmology, Daping Hospital, Army Medical Center, Army Medical University, Chongqing, People's Republic of China; 2 Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 3 Medico-Engineering Cooperation on Applied Medicine Research Center, University of Electronic Science and Technology of China, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fang Lu Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 The First Ring Road West 2, Chengdu, Sichuan, 610072, People's Republic of China Tel/Fax +86-028-87394201 Email Jian Ye Department of Ophthalmology, Daping Hospital, Army Medical Center, Army Medical University, No. 10, Changjiang Branch, Daping, Yuzhong District, Chongqing, 400042, People's Republic of China Tel/Fax +86-023-68811229 Email Background: Glaucoma is a group of retinal neurodegenerative diseases causing irreversible visual impairment. The pathogenesis of this disease is complicated. Studies have shown that the immune system is involved in the neurodegenerative process of glaucoma. There are continuous evidences that autoantibodies play a crucial role in the pathogenesis of glaucoma. However, focuses on B cells, the antibody-producing cells in glaucoma are surprisingly limited. Methods: Fresh peripheral blood samples were collected from 44 glaucoma patients (38 with primary angle-closure glaucoma (PACG) and 6 with (primary open-angle glaucoma POAG)) and 36 age-matched healthy donors (HD). Density gradient centrifugation was performed to obtain peripheral blood mononuclear cells (PBMC). Flow cytometry was performed to determine B cell phenotypes. The severity of glaucoma was determined based on the mean deviation (MD) of visual field. Results: In this study, we demonstrated that total B cells was significantly increased in glaucoma patients compared to HD. Next, we checked changes of different B cell subsets in glaucoma. Glaucoma patients were found to have a significant increase in the frequencies of antibody-secreting cells (ASC)/plasmablasts, naïve, and CD19 + CD27 − IgD − double negative (DN) subpopulations, but a decrease in the CD27 + IgD + unswitched memory compartment. Notably, we found that the increment of CD27 − IgD − DN B cells was significantly magnified according to the clinical severity. Conclusion: We demonstrate, for the first time, that peripheral B cell subsets are altered and unveil the correlation of a newly identified pro-inflammatory CD27 − IgD − DN subset with clinical features of glaucoma, suggesting that these B cell subsets could serve as potential biomarkers to monitor the disease progression of glaucoma patients. Keywords: glaucoma, B cells, CD27 − IgD − double negative B cells, retinal neurodegeneration Glaucoma is a group of neurodegenerative diseases with a complex pathogenesis, which mainly affects the retinal ganglion cells (RGC) and optic nerve (ON), leading to irreversible visual impairment. There are about 70 million glaucoma patients in the world, about half of them in Asia, while nearly 10 million glaucoma patients in China. 1,2 The pathogenesis of glaucoma is complicated and it is considered that high intraocular pressure (IOP) is the most important risk factor in the pathogenesis of glaucoma. IOP reduction surgery is still the most commonly used treatment for retinal damage of glaucoma, 3–5 but patients with elevated IOP do not necessarily suffer from RGC/ON damage, while patients with normal or effectively controlled IOP might still have progressive neurodegenerative damage. Therefore, more and more studies begin to pay attention to other factors that might be related to retinal neurodegeneration besides IOP, in order to find novel therapeutic intervention. 6,7 It has been implicated that there are other factors related to the pathogenesis of glaucoma, such as vascular factors, 8 high myopia, 9,10 oxidative stress, 11 and immune responses. 6,12 Increasing clinical and expe -Abstract Truncated-
immunology